M&A Deal Summary

ADDvise Group AB Acquires GraMedica

On September 15, 2021, ADDvise Group AB acquired medical products company GraMedica for 6M USD

Acquisition Highlights
  • This is ADDvise Group AB’s 2nd transaction in the Medical Products sector.
  • This is ADDvise Group AB’s 2nd largest (disclosed) transaction.
  • This is ADDvise Group AB’s 3rd transaction in the United States.
  • This is ADDvise Group AB’s 1st transaction in Michigan.

M&A Deal Summary

Date 2021-09-15
Target GraMedica
Sector Medical Products
Buyer(s) ADDvise Group AB
Deal Type Add-on Acquisition
Deal Value 6M USD
Advisor(s) Generational Capital Markets (Financial)

Target

GraMedica

Macomb, Michigan, United States
GraMedica is a global medical device company involved in new product development with medical education in orthopedics. It is specialized in the correction of foot and ankle instability, a root cause of many secondary conditions throughout the body. GraMedica was formed in 2003 and is based in Macomb, Michigan.

Search 205,905 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

ADDvise Group AB

Stockholm, Sweden

Category Company
Sector Retail
DESCRIPTION

ADDvise Group AB (publ) is an expanding group that offers total solutions in the form of products and services to healthcare and research facilities.


DEAL STATS #
Overall 3 of 3
Sector (Medical Products) 2 of 2
Type (Add-on Acquisition) 3 of 3
State (Michigan) 1 of 1
Country (United States) 3 of 3
Year (2021) 2 of 2
Size (of disclosed) 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-07-30 MediSuite

Cary, North Carolina, United States

MediSuite is a mail-order pharmacy, MediSuite provides men’s health generic drugs at significant cost savings. MediSuite only dispenses FDA-approved pharmaceuticals. MediSuite’s most popular drugs are the generics of Viagra® (Sildenafil) and Cialis® (Tadalafil). MediSuite was founded in 2013 and is based in Cary, North Carolina.

Buy $10M